Marcus Lindsköld
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marcus Lindsköld has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Jennifer Park
Department of Surgery, Sahlgrenska Academy Gothenburg University, Sahlgrenska University Hospital Gothenburg Sweden
2 shared publications - Martin Rutegård
Department of Surgery, SSORG—Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg , Gothenburg
2 shared publications Anders Gerdin
Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden
1 shared publicationEva Angenete
Department of Surgery, SSORG—Scandinavian Surgical Outcomes Research Group, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden
1 shared publication- Fredrik Jörgren
Department of Surgery, Hospital of Helsingborg, Lund University, Helsingborg, Sweden
1 shared publication Henrik Jutesten
Department of Surgery, Skåne University Hospital, Malmö, Sweden
1 shared publication
Latest Publications
- Open Access
- 20 July 2026
- Published by SAGE Publications in Scandinavian Journal of Surgery
- Vol. 115 (3) , 247-256
Minimal long-term impact of anastomotic leakage on quality of life after anterior resection for rectal cancer: A population-based cohort study
Background: Anastomotic leakage after anterior resection for rectal cancer is associated with long-term morbidity, such as bowel dysfunction, but its impact on health-related quality of life remains insufficiently studied. The aim of this study was to evaluate the association between anastomotic leakage and health-related quality of life 3 years after surgery. Methods: In this population-based prospective cohort study, patients who underwent anterior resection for rectal cancer in Sweden between 2015 and 2017 were identified through the Swedish Colorectal Cancer Registry. Health-related quality of life was assessed 3 years after surgery using the EORTC QLQ-C30 and QLQ-CR29 questionnaires. The primary outcome was the QLQ-C30 summary score. Targeted maximum likelihood estimation was applied to estimate the adjusted effect of anastomotic leakage on health-related quality of life. Results: Of 1778 eligible patients, 1178 (66.3%) responded, including 104 (8.8%) with anastomotic leakage. Patients with anastomotic leakage reported a lower mean QLQ-C30 summary score compared to those without anastomotic leakage (80 vs 86, p < 0.001). After adjustment for confounders, anastomotic leakage was associated with a 4-point difference in summary score (p < 0.01). Patients with anastomotic leakage also reported worse body image. Compared with patients without anastomotic leakage, those with anastomotic leakage and no stoma reported more perianal skin irritation, while those with a stoma more frequently reported stool leakage from the stoma bag. Conclusions: Anastomotic leakage after anterior resection is associated with a small negative effect on overall health-related quality of life 3 years after surgery. Nevertheless, specific functional impairments—particularly related to body image, and stoma- or perianal symptoms—persist and warrant attention. These findings highlight the importance of patient counseling and long-term follow-up after anastomotic leakage.
- 20 July 2026
- Published by SAGE Publications in Scandinavian Journal of Surgery
- Vol. 115 (3) , 247-256
Open AccessMinimal long-term impact of anastomotic leakage on quality of life after anterior resection for rectal cancer: A population-based cohort study
Background: Anastomotic leakage after anterior resection for rectal cancer is associated with long-term morbidity, such as bowel dysfunction, but its impact on health-related quality of life remains insufficiently studied. The aim of this study was to evaluate the association between anastomotic leakage and health-related quality of life 3 years after surgery. Methods: In this population-based prospective cohort study, patients who underwent anterior resection for rectal cancer in Sweden between 2015 and 2017 were identified through the Swedish Colorectal Cancer Registry. Health-related quality of life was assessed 3 years after surgery using the EORTC QLQ-C30 and QLQ-CR29 questionnaires. The primary outcome was the QLQ-C30 summary score. Targeted maximum likelihood estimation was applied to estimate the adjusted effect of anastomotic leakage on health-related quality of life. Results: Of 1778 eligible patients, 1178 (66.3%) responded, including 104 (8.8%) with anastomotic leakage. Patients with anastomotic leakage reported a lower mean QLQ-C30 summary score compared to those without anastomotic leakage (80 vs 86, p < 0.001). After adjustment for confounders, anastomotic leakage was associated with a 4-point difference in summary score (p < 0.01). Patients with anastomotic leakage also reported worse body image. Compared with patients without anastomotic leakage, those with anastomotic leakage and no stoma reported more perianal skin irritation, while those with a stoma more frequently reported stool leakage from the stoma bag. Conclusions: Anastomotic leakage after anterior resection is associated with a small negative effect on overall health-related quality of life 3 years after surgery. Nevertheless, specific functional impairments—particularly related to body image, and stoma- or perianal symptoms—persist and warrant attention. These findings highlight the importance of patient counseling and long-term follow-up after anastomotic leakage.
- Open Access
- 30 January 2025
- Published by Wiley in Colorectal Disease
- Vol. 27 (2) , e70009
SELective defunctioning Stoma Approach in low anterior resection for rectal cancer (SELSA): Protocol for a prospective study with a nested randomized clinical trial investigating stoma‐free survival without major LARS following total mesorectal excision
Aim: Accumulated data suggest that routine use of defunctioning stoma in low anterior resection for rectal cancer may cause kidney injury, bowel dysfunction and a higher risk of permanent stomas. We aim to study whether avoidance of a diverting stoma in selected patients is safe and reduces adverse consequences.Methods: SELSA is a multicentre international prospective observational study nesting an open‐label randomized clinical trial. All patients with primary rectal cancer planned for low anterior resection are eligible. Patients operated with curative intent, aged <80 years, with an American Society of Anaesthesiologists' fitness grade I or II, and a low predicted risk of anastomotic leakage are eligible to 1:1 randomization between no defunctioning stoma (experimental arm) or a defunctioning stoma (control arm). The primary outcome is the composite measure of 2‐year stoma‐free survival without major low anterior resection syndrome (LARS). Secondary outcomes include anastomotic leakage, postoperative mortality, reinterventions, stoma‐related complications, quality of life measures, LARS score, and permanent stoma rate. To be able to state superiority of any study arm regarding the main outcome, with 90% statistical power and assuming 25% attrition, we aim to enrol 212 patients. Patient inclusion will commence in the autumn of 2024.Conclusion: The SELSA study is investigating a tailored approach to defunctioning stoma use in low anterior resection for rectal cancer in relation to the risk of anastomotic leakage. Our hypothesis is that long‐term effects will favour the selective approach, enabling some patients to avoid a defunctioning stoma.Trial registration: Swedish Ethical Review Authority approval (2023–04347‐01, 2024–02418‐02 and 2024–03622‐02), Regional Ethics Committee Denmark (H‐24014463), and ClinicalTrials.gov (NCT06214988).
- 30 January 2025
- Published by Wiley in Colorectal Disease
- Vol. 27 (2) , e70009
Open AccessSELective defunctioning Stoma Approach in low anterior resection for rectal cancer (SELSA): Protocol for a prospective study with a nested randomized clinical trial investigating stoma‐free survival without major LARS following total mesorectal excision
Aim: Accumulated data suggest that routine use of defunctioning stoma in low anterior resection for rectal cancer may cause kidney injury, bowel dysfunction and a higher risk of permanent stomas. We aim to study whether avoidance of a diverting stoma in selected patients is safe and reduces adverse consequences.Methods: SELSA is a multicentre international prospective observational study nesting an open‐label randomized clinical trial. All patients with primary rectal cancer planned for low anterior resection are eligible. Patients operated with curative intent, aged <80 years, with an American Society of Anaesthesiologists' fitness grade I or II, and a low predicted risk of anastomotic leakage are eligible to 1:1 randomization between no defunctioning stoma (experimental arm) or a defunctioning stoma (control arm). The primary outcome is the composite measure of 2‐year stoma‐free survival without major low anterior resection syndrome (LARS). Secondary outcomes include anastomotic leakage, postoperative mortality, reinterventions, stoma‐related complications, quality of life measures, LARS score, and permanent stoma rate. To be able to state superiority of any study arm regarding the main outcome, with 90% statistical power and assuming 25% attrition, we aim to enrol 212 patients. Patient inclusion will commence in the autumn of 2024.Conclusion: The SELSA study is investigating a tailored approach to defunctioning stoma use in low anterior resection for rectal cancer in relation to the risk of anastomotic leakage. Our hypothesis is that long‐term effects will favour the selective approach, enabling some patients to avoid a defunctioning stoma.Trial registration: Swedish Ethical Review Authority approval (2023–04347‐01, 2024–02418‐02 and 2024–03622‐02), Regional Ethics Committee Denmark (H‐24014463), and ClinicalTrials.gov (NCT06214988).